Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1746-1756
Closed Access | Times Cited: 10

Showing 10 citing articles:

Virologic Response at 12 Months Predicts Lower Hepatocellular Carcinoma Risk in Genotype D Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues
Oğuzhan Öztürk, Fatih Güzelbulut, Kâmil Özdil, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2618-2618
Open Access
Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: a ten-year retrospective cohort study
Jian Liu, Shilei Bai, Xintong Shi, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 5, pp. 109621-109621
Closed Access
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase
Lung‐Yi Mak, Leland J. Yee, Robert J. Wong, et al.
Journal of Viral Hepatitis (2024)
Open Access | Times Cited: 2
In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients
Juan Yang, He Gao, Tiantian Zhang, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 600-600
Open Access | Times Cited: 1
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B
Nobuharu Tamaki, Mayu Higuchi, Taisei Keitoku, et al.
JGH Open (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 1
Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia
Yu‐Ching Chen, Chun‐Chi Yang, Hsing‐Tao Kuo, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 9, pp. 1661-1671
Open Access | Times Cited: 1
Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis
Uttam Ojha, Somi Kim, Chang Yun Rhee, et al.
Hepatology (2024)
Closed Access | Times Cited: 1
The antiviral treatment should be initiated before the development of cirrhosis
Qiao Tang, Peng Hu
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 1, pp. 136-138
Open Access
Effects of Bushen Huayu Decoction combined with entecavir on liver function and hepatic fibrosis in patients with compensated cirrhosis
Wei Yu, GE Chang-qing
American Journal of Translational Research (2024) Vol. 16, Iss. 8, pp. 4163-4173
Closed Access
Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
Weichun Lin, Ke Lin, Mingkai Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 11, pp. 1321-1230
Closed Access
Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: a ten-year cohort study
Jian Liu, Jianbo Lin, Xintong Shi, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top